Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133913
Status:
UNKNOWN
Last Update Posted:
2008-03-19
First Post:
2005-08-22
Brief Title:
Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
Sponsor:
Immunicon
Organization:
Immunicon
Study Overview
Official Title:
Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas
Status:
UNKNOWN
Status Verified Date:
2008-03
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMMC-06
Brief Summary:
This study enrolled patients with measurable metastatic colorectal cancer Blood was drawn prior to the patient receiving a new therapy for hisher cancer and subsequently at 7-14 days 3-4 weeks and when an imaging study was done every 6 to 12 weeks The blood was tested to find circulating tumor cells CTCs and to count them The CTC levels were compared to the imaging study results to see if the CTC number and the imaging result progressionno progression were in agreement Maximum active study participation was 12 months with up to 8 blood draws being taken All patients are currently being followed for up to 24 months from their off study date for survival The CTC result will also be used to see if there is a difference in survival and progression-free survival for those patients with and without a certain number of CTCs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None